We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

65 hedge funds and large institutions have $195M invested in Autolus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

454% more call options, than puts

Call options by funds: $72K | Put options by funds: $13K

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

4% less capital invested

Capital invested by funds: $204M → $195M (-$9.03M)

3.41% less ownership

Funds ownership: 64.69% → 61.28% (-3.4%)

8% less funds holding

Funds holding: 71 → 65 (-6)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
65
Holders Change
-6
Holders Change %
-8.45%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
20
Reduced
11
Closed
14
Calls
$72K
Puts
$13K
Net Calls
+$59K
Net Calls Change
-$272K

Top Buyers

Rank Fund Capital Flow
1
TAM
TFG Asset Management
Cayman Islands
+$3.32M
2
UOC
UBS O'Connor
Illinois
+$1.48M
3
BlackRock
BlackRock
New York
+$925K
4
Millennium Management
Millennium Management
New York
+$458K
5
IAM
Innovis Asset Management
Illinois
+$247K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.44M
2
CH
CVI Holdings
Delaware
-$2.35M
3
Capital World Investors
Capital World Investors
California
-$1.19M
4
AC
Armistice Capital
New York
-$1.08M
5
SFM
Sphera Funds Management
Israel
-$950K
Name Holding Trade Value Shares
Change 		Change in
Stake
William Blair & Company
51
William Blair & Company
Illinois
$24.1K -$457 -234 -2%
Acadian Asset Management
52
Acadian Asset Management
Massachusetts
$22K -$19.2K -9,833 -45%
UBV
53
United Bank (Virginia)
Virginia
$19K – – –
BAM
54
Bayshore Asset Management
Florida
$18.4K – – –
Lazard Asset Management
55
Lazard Asset Management
New York
$18K +$12.5K +6,416 +171%
FWM
56
Focused Wealth Management
New York
$9.2K +$9.78K +5,000 New
QCG
57
Quadrant Capital Group
Ohio
$7.13K +$5.91K +3,024 +356%
LC
58
Lindbrook Capital
California
$3.56K – – –
HNB
59
Huntington National Bank
Ohio
$2.76K – – –
Fidelity Investments
60
Fidelity Investments
Massachusetts
$2.08K – – –
UIA
61
Ulland Investment Advisors
Minnesota
$2K – – –
Bank of America
62
Bank of America
North Carolina
$1.2K +$266 +136 +26%
CAM
63
Close Asset Management
United Kingdom
$1K +$978 +500 New
CHA
64
Carmichael Hill & Associates
Maryland
$935 – – –
SOW
65
State of Wyoming
Wyoming
$386 -$16 -8 -4%
CH
66
CVI Holdings
Delaware
– -$2.35M -1,237,511 Closed
Capital World Investors
67
Capital World Investors
California
– -$1.19M -625,000 Closed
SFM
68
Sphera Funds Management
Israel
– -$950K -500,000 Closed
PCM
69
Pentwater Capital Management
Florida
– -$760K -400,000 Closed
CCM
70
CAAS Capital Management
New York
– -$613K -322,795 Closed
E
71
Ergoteles
New York
– -$321K -169,180 Closed
CC
72
Covalis Capital
United Kingdom
– -$129K -67,767 Closed
AGM
73
Alpine Global Management
New York
– -$38K -19,885 Closed
SEI Investments
74
SEI Investments
Pennsylvania
– -$28.6K -15,040 Closed
Corient Private Wealth
75
Corient Private Wealth
Florida
– -$28.5K -15,000 Closed
1 2
3
4

AUTL Hedge Fund Activity: Q1 2023 in Review

65 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q1 2023, worth a combined $195M — down 4.4% from $204M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AUTL and 9 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 20 added.

The largest buyer was TFG Asset Management, adding an estimated $3.32M. The largest seller was Alyeska Investment Group, cutting an estimated $2.44M.

  • 65 institutional investors held Autolus Therapeutics (AUTL) as of Q1 2023, down from 71 in Q4 2022.
  • Funds reported $195M of Autolus Therapeutics stock for Q1 2023, down 4.4% quarter-over-quarter.
  • 9 funds opened new Autolus Therapeutics positions in Q1 2023 and 14 closed out, a net change of -5 holders.
  • The largest Autolus Therapeutics buyer in Q1 2023 was TFG Asset Management, an estimated $3.32M added.
  • The largest Autolus Therapeutics seller in Q1 2023 was Alyeska Investment Group, an estimated $2.44M sold.

Based on aggregated 13F filings for Q1 2023.